NOTTINGHAM, England--(BUSINESS WIRE)--Neupulse has secured funding to advance the world’s first wearable device aimed at tackling Tourettes Syndrome (TS) and other tic disorders towards ...

Two technologies that are based on research by University of Nottingham experts to reduce the severity of tics in people with Tourette syndrome (TS) are closer to patient use after being recommended ...

A University of Nottingham spin-out behind a wrist device designed to help control Tourette's Syndrome has raised more than £900,000 in additional funding. Neupulse has completed a second round of ...

The National Institute for Health and Care Excellence (NICE) has approved two technologies for treating chronic tic disorders and Tourette syndrome. The Online Remote Behavioural Intervention for Tics ...

Neupulse, a neurotherapeutics company developing solutions for brain health conditions such as Tourette's syndrome, has raised £3m to accelerate its path to market. The funding round was led by Eos ...

A new wrist device to help control Tourette’s Syndrome is a step closer to being commercialised after University of Nottingham spin-out company Neupulse raised almost £1m in additional funding.

Biopharma and med-tech companies raising money in public or private financings, including: Berlin Heals, Biorestorative, Entirety, Nektar, Neupulse, Neurent, Xilio.

On Tuesday, Dec. 30, the TLC series aired the last episode of Season 2, during which Baylen, her fiancé, Colin Dooley, and her family traveled to the U.K. to test out a new Tourette syndrome treatment ...